(Q83525180)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19309637%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

editorial

0 references

title

When is being in a hurry going too fast? Lessons learned from clinical trials in cervical cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19309637%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference

cervix uterine cancer

1 reference

1

Bradley J Monk

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19309637%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

Shamshad Ali

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19309637%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

David K Gaffney

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19309637%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

publication date

1 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19309637%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19309637%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

volume

113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19309637%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19309637%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

page(s)

1-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19309637%20AND%20SRC:MED&resulttype=core&format=json

Global cancer statistics, 2002

24 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.015

Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.015

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.015

A Phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.015

Efficacy and patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in RTOG 0128

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.015

Radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in cervical carcinoma limited to the pelvis: a phase I/II study of the Gynecologic Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.015

A phase I/II evaluation of tirapazamine administered intravenously concurrent with cisplatin and radiotherapy in women with locally advanced cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.015

Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.015

Phase I study of paclitaxel and topotecan for the first-line treatment of extensive-stage small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.015

Weekly administration of topotecan and paclitaxel in pretreated advanced cancer patients: a phase I/II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.015

Weekly administration of topotecan-paclitaxel as second-line treatment in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.015

A phase I study of weekly topotecan and Paclitaxel in previously treated epithelial ovarian carcinoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.015

Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.015

Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.02.015

10.1016/J.YGYNO.2009.02.015

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19309637%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference